ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 75 filers reported holding ADMA BIOLOGICS INC in Q4 2019. The put-call ratio across all filers is 2.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $106,400 | -69.8% | 28,835 | -72.9% | 0.00% | -66.7% |
Q1 2023 | $352,011 | -74.9% | 106,348 | -70.6% | 0.00% | -75.0% |
Q4 2022 | $1,404,998 | -31.1% | 362,113 | -56.8% | 0.01% | -29.4% |
Q3 2022 | $2,038,000 | -2.8% | 838,466 | -20.8% | 0.02% | -15.0% |
Q2 2022 | $2,096,000 | -7.6% | 1,058,641 | -14.6% | 0.02% | 0.0% |
Q1 2022 | $2,269,000 | +136.4% | 1,239,656 | +82.1% | 0.02% | +122.2% |
Q4 2021 | $960,000 | +1016.3% | 680,684 | +795.6% | 0.01% | +800.0% |
Q3 2021 | $86,000 | -87.8% | 76,000 | -82.8% | 0.00% | -87.5% |
Q2 2021 | $707,000 | -42.0% | 441,873 | -36.2% | 0.01% | -46.7% |
Q1 2021 | $1,219,000 | +9.0% | 692,287 | +20.7% | 0.02% | 0.0% |
Q4 2020 | $1,118,000 | -36.0% | 573,573 | -21.6% | 0.02% | -54.5% |
Q3 2020 | $1,748,000 | -49.2% | 731,723 | -37.7% | 0.03% | -28.3% |
Q2 2020 | $3,440,000 | +65.1% | 1,173,834 | +62.3% | 0.05% | -64.9% |
Q1 2020 | $2,083,000 | -58.0% | 723,427 | -41.7% | 0.13% | +8.3% |
Q4 2019 | $4,963,000 | -29.0% | 1,240,793 | -21.0% | 0.12% | -41.0% |
Q3 2019 | $6,988,000 | -16.7% | 1,570,408 | -27.5% | 0.20% | -30.7% |
Q2 2019 | $8,384,000 | +882.9% | 2,166,400 | +862.8% | 0.30% | +886.7% |
Q1 2019 | $853,000 | – | 225,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|